Common use of EARLY TERMINATION OF THE RESEARCH PROGRAM Clause in Contracts

EARLY TERMINATION OF THE RESEARCH PROGRAM. The Research Program may be terminated by either Party, such termination not otherwise to affect any other rights or obligations of the Parties under this Agreement, including without limitation commercialization rights, as follows: (a) PathoGenesis may terminate the Research Program if Novartis exercises its rights to control Chiron in accordance with Section 1.3 by providing six months written notice of termination to Chiron, such notice to be provided no sooner than six months after Novartis' exercise of its rights to control Chiron in accordance with Section 1.3 hereof; or (b) Either Party may terminate the Research Program after a Change In Control of the other Party by providing six months written notice to the other Party, such notice to be provided no sooner than six months after the Change in Control has taken place.

Appears in 3 contracts

Sources: Collaboration Agreement (Pathogenesis Corp), Collaboration Agreement (Pathogenesis Corp), Collaboration Agreement (Pathogenesis Corp)